Most patients lose 1–3 pounds per week once treatment begins, with appetite changes often noticeable within the first few days. Clinical data shows average weight loss of 15–20% of body weight over 12 months when medication is paired with lifestyle changes. Your results depend on medication adherence, your starting point, and how consistently you implement the habits we teach. We're transparent: this isn't a quick fix. It's a reset of the biology that's been working against you.

Weight can return. GLP-1 medications address the hormonal signals that drive hunger and fat storage—when you stop, those signals come back. That's why our program focuses on building sustainable habits alongside medication, so you're not dependent on the drug forever. Some patients transition off successfully after reaching their goals; others stay on maintenance doses long-term. We'll help you find the right path.

Our monthly membership is $149, which includes clinician consultations, ongoing support, and care coordination. Medication costs vary depending on what's prescribed and your insurance coverage—ranging from $25/month with good coverage to $300+ without. We'll give you a clear cost estimate before you commit to anything.

It depends on your plan. Many insurers now cover GLP-1 medications, especially if you have weight-related conditions like type 2 diabetes or high blood pressure. We handle the insurance paperwork and prior authorizations for you. If your plan doesn't cover it, we'll discuss alternatives—including compounded options that can significantly reduce out-of-pocket costs.

We prescribe FDA-approved GLP-1 medications including semaglutide (Wegovy®, Ozempic®), tirzepatide (Mounjaro®, Zepbound®), and liraglutide (Saxenda®). Your clinician selects the right medication based on your health history, goals, and insurance situation. We also offer compounded semaglutide and tirzepatide for patients who need a more affordable option.

Both are weekly injections that reduce appetite and improve blood sugar control. Semaglutide targets GLP-1 receptors. Tirzepatide targets both GLP-1 and GIP receptors, a dual mechanism that may produce stronger effects for some patients. Your clinician will recommend the best fit based on your profile.

The most common side effects are mild and temporary: nausea, occasional vomiting, constipation, or diarrhea. These typically fade as your body adjusts. We start you at a low dose and increase gradually to minimize discomfort. If side effects persist, your clinician will adjust your protocol. These medications are FDA-approved and extensively studied, but they're not appropriate for everyone. We screen for contraindications (like certain thyroid conditions or history of pancreatitis) before prescribing.